The addition of pyloroplasty as a new surgical approach to enhance effectiveness of gastric electrical stimulation therapy in patients with gastroparesis
- 31 October 2012
- journal article
- clinical trial
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 25 (2), 134-e80
- https://doi.org/10.1111/nmo.12032
Abstract
Improvement of gastroparesis (GP) symptoms has been documented in patients treated with gastric electrical stimulation (GES), but acceleration of gastric emptying (GET) is unpredictable. The aim of our study was to evaluate the advantage of adding surgical pyloroplasty (PP) to GES for improvement of GET and control of symptoms in diabetes mellitus (DM), idiopathic (ID), and postvagotomy (P-V) GP. A total of 49 (17 - DM, 9 - ID, 23 - P-V) consecutive GP patients: 38 female; mean age 42 (21-73 years); mean weight 158 lbs (102-245), underwent GES implantation, and 26 (53%) additionally received PP. Total Symptoms Score, 4-h GET, adverse events (AEs), and days of hospitalizations were captured at baseline and at the last visit. The mean follow-up was 7 months. Total Symptoms Score in patients who received Enterra and PP or GES alone significantly improved compared to their baseline scores (P < 0.001). GET improved by 64% at 4 h (P < 0.001) in patients with Enterra and PP, compared to 7% observed after GES therapy alone (ns). The most impressive acceleration of GET was seen in the P-V group, who received both therapies (P = 0.004) and 8 (60%) of them normalized GET. No AEs accompanied the addition of PP to the Enterra surgery. (i) In drug-refractory GP the addition of PP to GES substantially accelerated GET; (ii) The GET response in P-V group was the most impressive; (iii) Significant symptom reductions were achieved by both procedures; and (iv) PP added to GES may sustain better long-term symptoms control particularly in the P-V setting.Keywords
This publication has 43 references indexed in Scilit:
- Review article: gastric electrical stimulation for gastroparesis – physiological foundations, technical aspects and clinical implicationsAlimentary Pharmacology & Therapeutics, 2009
- Endoscopic Pyloric Injection of Botulinum Toxin-A for the Treatment of Postvagotomy GastroparesisThe American Journal of the Medical Sciences, 2009
- Pharmacotherapy of gastroparesisExpert Opinion on Pharmacotherapy, 2009
- Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retentionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- T1413 The Addition of Pyloroplasty Is a New Surgical Approach That Enhances the Clinical Outcome to Gastric Electrical Stimulation (Enterra) in Patients with Post-Vagotomy Gastroparesis Compared to Diabetic/Idiopathic GastroparesisGastroenterology, 2008
- Treatment of Gastroparesis: An UpdateDigestion, 2008
- Gastroparesis: Symptoms, Evaluation, and TreatmentGastroenterology Clinics of North America, 2007
- Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findingsJournal of Gastrointestinal Surgery, 2005
- Effect of high‐frequency gastric electrical stimulation on gastric myoelectric activity in gastroparetic patientsNeurogastroenterology & Motility, 2004
- Functional and symptomatic improvement in patients with diabetic gastroparesis following pyloroplastyGastroenterology, 1998